Cargando…

Cohort profile: radiotherapy dataset (RTDS) in England

PURPOSE: The purpose of the Radiotherapy Dataset (RTDS) is to collect consistent and comparable data across all providers of National Health Service (NHS)-funded radiotherapy and to provide intelligence for service planning, commissioning, clinical practice and research. PARTICIPANTS: The RTDS is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandhu, Sabrina, Sharpe, Michael, Findlay, Úna, Roe, Catherine, Broggio, John, Spencer, Katie, Thackray, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314480/
https://www.ncbi.nlm.nih.gov/pubmed/37339842
http://dx.doi.org/10.1136/bmjopen-2022-070699
_version_ 1785067318689136640
author Sandhu, Sabrina
Sharpe, Michael
Findlay, Úna
Roe, Catherine
Broggio, John
Spencer, Katie
Thackray, Katherine
author_facet Sandhu, Sabrina
Sharpe, Michael
Findlay, Úna
Roe, Catherine
Broggio, John
Spencer, Katie
Thackray, Katherine
author_sort Sandhu, Sabrina
collection PubMed
description PURPOSE: The purpose of the Radiotherapy Dataset (RTDS) is to collect consistent and comparable data across all providers of National Health Service (NHS)-funded radiotherapy and to provide intelligence for service planning, commissioning, clinical practice and research. PARTICIPANTS: The RTDS is a mandated dataset requiring providers to collect and submit data monthly for patients treated in England. Data is available from 01 April 2009 to 2 months behind the calendar month. The National Disease Registration Service (NDRS) started receiving data from 01 April 2016. Prior to this, the National Clinical Analysis and Specialised Applications Team (NATCANSAT) were responsible for the RTDS. NDRS holds a copy of the NATCANSAT data for English NHS providers. The RTDS contains clinical information on the primary disease being treated, modality and intent of treatment, dose fractionation and hospital appointment details. Due to constraints in RTDS coding, linkage to the English National Cancer Registration dataset is beneficial. FINDINGS TO DATE: The RTDS has been linked to the English National Cancer Registration and Systemic Anti-Cancer Therapy (SACT) datasets and to Hospital Episode Statistics (HES) to provide a more complete picture of the patient cancer pathway. Findings include a study to compare outcomes for patients treated with radical radiotherapy, an investigation of factors influencing 30-day mortality, assessing sociodemographic variation in the use of treatment and a study to assess the service impact of the COVID-19 pandemic. A range of other studies have been completed or are ongoing currently. FUTURE PLANS: The RTDS can be used for a variety of functions including cancer epidemiological studies to investigate inequalities in treatment access; provide service planning intelligence; monitor clinical practice; and support clinical trial design and recruitment. Collection is to continue indefinitely, with regular updates to the data specification to enable capture of more detailed information on radiotherapy planning and delivery.
format Online
Article
Text
id pubmed-10314480
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103144802023-07-02 Cohort profile: radiotherapy dataset (RTDS) in England Sandhu, Sabrina Sharpe, Michael Findlay, Úna Roe, Catherine Broggio, John Spencer, Katie Thackray, Katherine BMJ Open Epidemiology PURPOSE: The purpose of the Radiotherapy Dataset (RTDS) is to collect consistent and comparable data across all providers of National Health Service (NHS)-funded radiotherapy and to provide intelligence for service planning, commissioning, clinical practice and research. PARTICIPANTS: The RTDS is a mandated dataset requiring providers to collect and submit data monthly for patients treated in England. Data is available from 01 April 2009 to 2 months behind the calendar month. The National Disease Registration Service (NDRS) started receiving data from 01 April 2016. Prior to this, the National Clinical Analysis and Specialised Applications Team (NATCANSAT) were responsible for the RTDS. NDRS holds a copy of the NATCANSAT data for English NHS providers. The RTDS contains clinical information on the primary disease being treated, modality and intent of treatment, dose fractionation and hospital appointment details. Due to constraints in RTDS coding, linkage to the English National Cancer Registration dataset is beneficial. FINDINGS TO DATE: The RTDS has been linked to the English National Cancer Registration and Systemic Anti-Cancer Therapy (SACT) datasets and to Hospital Episode Statistics (HES) to provide a more complete picture of the patient cancer pathway. Findings include a study to compare outcomes for patients treated with radical radiotherapy, an investigation of factors influencing 30-day mortality, assessing sociodemographic variation in the use of treatment and a study to assess the service impact of the COVID-19 pandemic. A range of other studies have been completed or are ongoing currently. FUTURE PLANS: The RTDS can be used for a variety of functions including cancer epidemiological studies to investigate inequalities in treatment access; provide service planning intelligence; monitor clinical practice; and support clinical trial design and recruitment. Collection is to continue indefinitely, with regular updates to the data specification to enable capture of more detailed information on radiotherapy planning and delivery. BMJ Publishing Group 2023-06-20 /pmc/articles/PMC10314480/ /pubmed/37339842 http://dx.doi.org/10.1136/bmjopen-2022-070699 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Sandhu, Sabrina
Sharpe, Michael
Findlay, Úna
Roe, Catherine
Broggio, John
Spencer, Katie
Thackray, Katherine
Cohort profile: radiotherapy dataset (RTDS) in England
title Cohort profile: radiotherapy dataset (RTDS) in England
title_full Cohort profile: radiotherapy dataset (RTDS) in England
title_fullStr Cohort profile: radiotherapy dataset (RTDS) in England
title_full_unstemmed Cohort profile: radiotherapy dataset (RTDS) in England
title_short Cohort profile: radiotherapy dataset (RTDS) in England
title_sort cohort profile: radiotherapy dataset (rtds) in england
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314480/
https://www.ncbi.nlm.nih.gov/pubmed/37339842
http://dx.doi.org/10.1136/bmjopen-2022-070699
work_keys_str_mv AT sandhusabrina cohortprofileradiotherapydatasetrtdsinengland
AT sharpemichael cohortprofileradiotherapydatasetrtdsinengland
AT findlayuna cohortprofileradiotherapydatasetrtdsinengland
AT roecatherine cohortprofileradiotherapydatasetrtdsinengland
AT broggiojohn cohortprofileradiotherapydatasetrtdsinengland
AT spencerkatie cohortprofileradiotherapydatasetrtdsinengland
AT thackraykatherine cohortprofileradiotherapydatasetrtdsinengland